School of Medicine

Researchers found that Rad9, previously considered a “watchman” that checks for DNA damage, is actually a “repairman” that fixes dangerous breaks in DNA. More medical news

The gray shading shows the areas surveyed for the study.A comparison of residential areas in the St. Louis region reveales that late middle-aged and older African-Americans who live in rundown neighborhoods with poor air and street quality are three times more likely to develop difficulties walking, standing, or lifting than those in cleaner, better-maintained areas.

Scientists have completed an extensive study of more than 3,000 patients who received a promising anti-inflammatory drug, natalizumab, that was linked to three cases of a serious brain infection in large clinical trials halted in early 2005.

A program designed by the Weight Management Center at the School of Medicine and the YMCA of Chesterfield has helped the Garcia family from Chesterfield lose roughly 105 pounds. The Family Lifestyle Intervention Program (FLIP) is designed to show families how to get healthy together through supervised exercise, counseling and education.

Such a “diet” helps make cardiovascular disease the most common killer of diabetic patients, according to a recently published School of Medicine study. More medical news

Simon Powell & Jeff Michalski have announced the appointment of Perry W. Grigsby, M.D., professor of radiation oncology, as the center’s director.

Photo by Robert BostonParticipants in the School of Medicine’s Executive master in health administration program play the “Red Bead Game.”The two-year executive master in health administration program was created specifically for 18 participants from the Riyadh-based King Fahad Medical City.

Researchers at the Genome Sequencing Center at the School of Medicine were major contributors to the monkey’s genome, made publicly available this month.

Small-scale preliminary trials suggested that careful control of blood pressure could possibly delay or even prevent kidney failure in patients with polycystic kidney disease (PKD), which affects more than 600,000 people in the United States.

Washington University has a long tradition of undergraduate participation in research, one developed further by programs created by Sarah Elgin, Ph.D., professor of biology; biochemistry and molecular biophysics; and education in Arts & Sciences with financial support from the Howard Hughes Medical Institute.